Details for New Drug Application (NDA): 205390
✉ Email this page to a colleague
NDA 205390 describes VECURONIUM BROMIDE, which is a drug marketed by Eugia Pharma, Gland, Hikma, Hospira, Meitheal, Mylan Labs Ltd, Sagent Pharms Inc, Sun Pharm, and Watson Labs, and is included in twelve NDAs. It is available from ten suppliers. Additional details are available on the VECURONIUM BROMIDE profile page.
The generic ingredient in VECURONIUM BROMIDE is vecuronium bromide. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the vecuronium bromide profile page.
The generic ingredient in VECURONIUM BROMIDE is vecuronium bromide. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the vecuronium bromide profile page.
Summary for 205390
| Tradename: | VECURONIUM BROMIDE |
| Applicant: | Gland |
| Ingredient: | vecuronium bromide |
| Patents: | 0 |
Pharmacology for NDA: 205390
| Physiological Effect | Neuromuscular Nondepolarizing Blockade |
Medical Subject Heading (MeSH) Categories for 205390
Suppliers and Packaging for NDA: 205390
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 205390 | ANDA | Sagent Pharmaceuticals | 25021-685 | 25021-685-10 | 10 VIAL in 1 CARTON (25021-685-10) / 10 mL in 1 VIAL |
| VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 205390 | ANDA | Sagent Pharmaceuticals | 25021-686 | 25021-686-20 | 10 VIAL in 1 CARTON (25021-686-20) / 20 mL in 1 VIAL |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/VIAL | ||||
| Approval Date: | May 26, 2016 | TE: | AP | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 20MG/VIAL | ||||
| Approval Date: | May 26, 2016 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
